| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2017 | Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review | Lin K.-Y.; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; Cheng A.; Sun H.-Y.; SUI-YUAN CHANG ; Liu C.-E.; Hung C.-C. | World Journal of Gastroenterology | 35 | 39 | |
| 2017 | Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review | Lin K.-Y.; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; Cheng A.; Sun H.-Y.; Chang S.-Y.; Liu C.-E.; CHIEN-CHING HUNG | World Journal of Gastroenterology | 39 | ||
| 2017 | Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review | Lin K.-Y.; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; Cheng A.; HSIN-YUN SUN ; Chang S.-Y.; Liu C.-E.; Hung C.-C. | World Journal of Gastroenterology | 39 | ||
| 2017 | Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review | Lin K.-Y.; Chen G.-J.; Lee Y.-L.; Huang Y.-C.; ARISTINE CHENG ; Sun H.-Y.; Chang S.-Y.; Liu C.-E.; Hung C.-C. | World Journal of Gastroenterology | 39 | ||
| 2020 | Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV | Chen G.-J.; Lee Y.-L.; Lee C.-H.; Sun H.-Y.; Cheng C.-Y.; Tsai H.-C.; Huang S.-H.; Lee Y.-C.; Hsieh M.-H.; Chang S.-Y.; Chuang Y.-C.; Su L.-S.; Chang S.-F.; Tang H.-J.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | The Journal of antimicrobial chemotherapy | 0 | ||
| 2020 | Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV | Chen G.-J.; Lee Y.-L.; Lee C.-H.; Sun H.-Y.; Cheng C.-Y.; Tsai H.-C.; Huang S.-H.; Lee Y.-C.; Hsieh M.-H.; Chang S.-Y.; YU-CHUNG CHUANG ; Su L.-S.; Chang S.-F.; Tang H.-J.; Hung C.-C. | Journal of Antimicrobial Chemotherapy | |||
| 2020 | Impact of archived M184V/I mutation on the effectiveness of switch to co-formulated elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide among virally suppressed people living with HIV | Chen G.-J.; Lee Y.-L.; Lee C.-H.; HSIN-YUN SUN ; Cheng C.-Y.; Tsai H.-C.; Huang S.-H.; Lee Y.-C.; Hsieh M.-H.; Chang S.-Y.; Chuang Y.-C.; Su L.-S.; Chang S.-F.; Tang H.-J.; Hung C.-C. | Journal of Antimicrobial Chemotherapy | 0 | ||
| 2012 | Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 | Huang C.-C.; Chen Y.-S.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Lu P.-L.; Liu C.-E.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Ko W.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 31 | 26 | |
| 2012 | Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 | Huang C.-C.; Chen Y.-S.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Lu P.-L.; Liu C.-E.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Ko W.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 26 | ||
| 2012 | In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Liu Y.-M.; Chen Y.-S.; Toh H.-S.; Huang C.-C.; Lee Y.-L.; Ho C.-M.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Liu C.-E.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 28 | 22 | |
| 2012 | In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Liu Y.-M.; Chen Y.-S.; Toh H.-S.; Huang C.-C.; Lee Y.-L.; Ho C.-M.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Liu C.-E.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 22 | ||
| 2014 | Infant sleep problems: A qualitative analysis of first-time mothers' coping experience | Tsai S.-Y.; Hu W.-Y.; Lee Y.-L.; CHIA-YI WU | Midwifery | 5 | 5 | |
| 2019 | Inhibitive properties of benzyldimethyldodecylammonium chloride on microbial corrosion of 304 stainless steel in a desulfovibrio desulfuricans-inoculated medium | Hsu C.-W.; Chen T.-E.; Lo K.-Y.; Lee Y.-L.; KAI-YIN LO | Materials | 1 | 1 | |
| 2011 | Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma | Chen S.-T.; Jeng Y.-M.; Chang C.-C.; Chang H.-H.; Huang M.-C.; Juan H.-F.; Hsu C.-H.; Lee H.; Liao Y.-F.; Lee Y.-L.; Hsu W.-M.; HONG-SHIEE LAI | Cancer Science | 18 | 18 | |
| 2011 | Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma | Chen S.-T.; Jeng Y.-M.; Chang C.-C.; Chang H.-H.; Huang M.-C.; Juan H.-F.; Hsu C.-H.; Lee H.; Liao Y.-F.; Lee Y.-L.; WEN-MING HSU ; Lai H.-S. | Cancer Science | 17 | 18 | |
| 2011 | Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma | Chen S.-T.; YUNG-MING JENG ; Chang C.-C.; Chang H.-H.; Huang M.-C.; Juan H.-F.; Hsu C.-H.; Lee H.; Liao Y.-F.; Lee Y.-L.; Hsu W.-M.; Lai H.-S. | Cancer Science | 17 | 18 | |
| 2011 | Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma | Chen S.-T.; Jeng Y.-M.; Chang C.-C.; Chang H.-H.; MIN-CHUAN HUANG ; Juan H.-F.; Hsu C.-H.; Lee H.; Liao Y.-F.; Lee Y.-L.; Hsu W.-M.; Lai H.-S. | Cancer Science | 17 | 18 | |
| 2011 | Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma | Chen S.-T.; Jeng Y.-M.; Chang C.-C.; HSIU-HAO CHANG ; Huang M.-C.; Juan H.-F.; Hsu C.-H.; Lee H.; Liao Y.-F.; Lee Y.-L.; Hsu W.-M.; Lai H.-S. | Cancer Science | 18 | ||
| 2002 | Interleukin-12 inhibits eotaxin secretion of cultured primary lung cells and alleviates airway inflammation in vivo | Ye Y.-L.; Huang W.-C.; Lee Y.-L.; BOR-LUEN CHIANG | Cytokine | 15 | 15 | |
| 2018 | Less severe but prolonged course of acute hepatitis a in Human Immunodeficiency Virus (HIV)-infected patients compared with HIV-uninfected patients during an outbreak: A multicenter observational study | Lee Y.-L.; Chen G.-J.; Chen N.-Y.; Liou B.-H.; Wang N.-C.; Lee Y.-T.; Yang C.-J.; Huang Y.-S.; Tang H.-J.; Huang S.-S.; Lin Y.-C.; Cheng C.-Y.; Lee C.-H.; Chen T.-C.; Wu T.-S.; Liu C.-E.; Lu P.-L.; CHIEN-CHING HUNG ; Lee Y.-C.; Cheng C.-Y.; Cheng S.-H.; Huang Y.-S.; Lee Y.-T.; Lin C.-C.; Lin S.-P.; Hsieh C.-Y.; Wang H.-W.; Ho M.-W.; Liu C.-E.; Lee Y.-L.; Lee Y.-C.; Tang H.-J.; Ku H.-C.; Li C.-W.; Lee N.-Y.; Ko W.-C.; Lu P.-L.; Chen Y.-H.; Lin H.-H.; Huang W.-C.; Lee C.-H.; Che T.-C. | Clinical Infectious Diseases | 11 |
